Ege David S.

Track

Insider profile

Ege David S.'s trades of Seres Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
446.18
Quantity 43,369 +18.7%
Value US$2,722,965
Transaction date
Planned sale
Price
468.30
Quantity 68,233 +5.3%
Value US$1,496,909
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-19 2024-08-16
PlS Planned sale
43,369 +18.7%
446.18
US$2,722,965 		43,369 +18.7% 446.18 US$2,722,965
2024-05-17 2024-05-15
PlS Planned sale
81,141 -46.9%
344.30
US$527,637 		81,141 -46.9% 344.30 US$527,637
2024-02-16 2024-02-16
PlS Planned sale
68,233 +5.3%
468.30
US$1,496,909 		68,233 +5.3% 468.30 US$1,496,909
2023-10-31 2023-10-30
PlS Planned sale
4,066 -5.7%
1.35
US$5,489 		4,066 -5.7% 1.35 US$5,489
2023-05-01 2023-04-28
PlS Planned sale
7,038 -10.5%
5.19
US$36,527 		7,038 -10.5% 5.19 US$36,527
2022-10-31 2022-10-31
PlS Planned sale
5,012 -9.7%
7.93
US$39,745 		5,012 -9.7% 7.93 US$39,745